coeliac disease
DISEASE INTERVENTION COMPARISON RESULTS
Aliment Pharmacol Ther. 2006 Jul 1;24(1):47-54 Meta-Analysis
IN coeliac disease The Use of
human recombinant tissue transglutaminase antibody
As Diagnostic Tool
Is better Than
endomysial antibody
To sreen asymptomatic people and for excluding coeliac disease in symptomatic individuals with a low pretest probability (i.e. <25%), if pretest probability >25%, biopsy should be preferred. Sensitivity 93%, specificity 98%.
Aliment Pharmacol Ther. 2008 Jun 1;27(11):1044-52 Systematic Review
IN coeliac disease The Use of
intake of a little amount of gluten (<10 mg/day)
As Etiologic risk factor
Is better Than
higher intake of gluten
To avoid cause significant histological abnormalities